Third Harmonic Bio upgraded by Morgan Stanley with a new price target
$THRD
Biotechnology: Pharmaceutical Preparations
Health Care
Morgan Stanley upgraded Third Harmonic Bio from Equal-Weight to Overweight and set a new price target of $20.00 from $12.00 previously